TRANSFARMACO
TRANSFARMACO, headquartered in Argentina, is a leading player in the pharmaceutical industry, specialising in the development and distribution of high-quality healthcare products. Founded in 1992, the company has established a strong presence across Latin America, focusing on innovative solutions in the fields of prescription medications and over-the-counter products. With a commitment to excellence, TRANSFARMACO offers a diverse portfolio that includes unique formulations and generics, catering to various therapeutic areas. The company is recognised for its rigorous quality standards and dedication to research and development, positioning it as a trusted name in the market. Notable achievements include significant growth in market share and a reputation for reliability among healthcare professionals.
DitchCarbon Score
How does TRANSFARMACO's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Maritime Transport industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TRANSFARMACO's score of 0 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TRANSFARMACO's reported carbon emissions
TRANSFARMACO, headquartered in Argentina (AR), currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of specific emissions data, it is important to note that TRANSFARMACO has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi). Additionally, there are no climate pledges mentioned that would indicate a structured approach towards reducing their carbon footprint. As the company navigates the evolving landscape of climate responsibility, it remains crucial for TRANSFARMACO to establish clear emissions data and set ambitious reduction targets to align with industry standards and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TRANSFARMACO is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
